BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.
Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?
Johnson & Johnson (NYSE: JNJ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for th
Moderna Announces Expanded Supply Agreement With Canada, Initiation Of mRNA Therapeutic Study For Inherited Disorder
Moderna Inc (NASDAQ: MRNA) announced a double dose of positive tidings Monday, but the stock is still wallowing in the red amid a sell-off seen across vaccine stocks.
Jim Lebenthal Likes AbbVie Stock At Its Current Price
It's a great time to invest in pharmaceutical companies such as AbbVie Inc (NYSE: ABBV), Cerity Partners' Jim Lebenthal shared Wednesday on CNBC's "Fast Money Halftime Report."
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,